access

News

NICE backs AbbVie’s oral therapy for migraine prevention

AbbVie’s Aquipta has become the first once-daily oral therapy for both chronic and episodic migraine prevention to be recommended by NICE for NHS patients in England and W

News

UK survey finds deep ethnic divisions in cancer diagnosis

A UK report has found that people from minority ethnic backgrounds face an average delay of a year between first noticing symptoms and gaining a diagnosis, which is more t

News

Sarah was born with ADA-SCID but was fortunate to access gene therapy via a clinical trial

NHS trust bids to take license for abandoned gene therapy

An NHS trust has taken the pioneering step of applying to hold the marketing authorisation for a gene therapy for a rare disease that was abandoned by a biotech developer

News

President Joe Biden and Senator Bernie Sanders

Biden slams asthma inhaler prices in White House address

President Joe Biden has reiterated his pledge to take action against high drug prices and “beat big pharma,” singling out the cost of asthma inhalers in a speech delivered

Digital

Bridging the gap: Uniting stakeholders through a digital eco...

Our mothers are dying. In 2021, the United States saw 32.9 maternal deaths per 100,000 live births.

News

NICE no follows Scottish aye for rare disease drug Xenpozyme

NICE has turned down Sanofi’s Xenpozyme as a treatment for the rare disease acid sphingomyelinase deficiency (ASMD), creating a situation where access to the drug in the U

NICE backs AbbVie’s oral therapy for migraine prevention

UK survey finds deep ethnic divisions in cancer diagnosis

NHS trust bids to take license for abandoned gene therapy

Biden slams asthma inhaler prices in White House address

Bridging the gap: Uniting stakeholders through a digital eco...

NICE no follows Scottish aye for rare disease drug Xenpozyme

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

access

Editor's Picks